Organogenesis Holdings (ORGO) Long-Term Deferred Tax (2017 - 2026)
Organogenesis Holdings (ORGO) posted quarterly Long-Term Deferred Tax of $45.3 million for Q1 2026, up 11.31% year-over-year from $40.7 million in Q1 2025, and up 51.3% quarter-over-quarter from $30.0 million in Q4 2025.
Organogenesis Holdings (ORGO) Long-Term Deferred Tax (2017 - 2026) Analysis & Trends
Organogenesis Holdings' Long-Term Deferred Tax history runs 10 years deep, the most recent figure standing at $45.3 million for Q1 2026.
- In Q1 2026, Long-Term Deferred Tax rose 11.31% year-over-year to $45.3 million; the TTM figure through Mar 2026 stood at $45.3 million (up 11.31% YoY), while the FY2025 annual figure was $30.0 million, down 24.07% from the prior year.
- Long-Term Deferred Tax for Q1 2026 stood at $45.3 million, up from $30.0 million in the prior quarter.
- The five-year high for Long-Term Deferred Tax was $45.6 million in Q3 2025, with the low at $28.0 million in Q4 2023.
- The 5-year median for Long-Term Deferred Tax is $32.0 million (2022), against an average of $34.4 million.
- The sharpest annual moves came in 2022 and 2025: Long-Term Deferred Tax soared 177644.44% in 2022, then slipped 24.07% in 2025.
- Organogenesis Holdings' Long-Term Deferred Tax stood at $30.0 million in 2022, then retreated by 6.7% to $28.0 million in 2023, then soared by 40.93% to $39.5 million in 2024, then retreated by 24.07% to $30.0 million in 2025, then soared by 51.3% to $45.3 million in 2026.
- Business Quant data shows ORGO's Long-Term Deferred Tax at $45.3 million in Q1 2026, $30.0 million in Q4 2025, and $45.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Organogenesis Holdings | 229.04 Mn | 182.20 Mn | 20.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 45.33 Mn |
| Dec 31, 2025 | 29.96 Mn |
| Sep 30, 2025 | 45.59 Mn |
| Jun 30, 2025 | 41.75 Mn |
| Mar 31, 2025 | 40.73 Mn |
| Dec 31, 2024 | 39.46 Mn |
| Sep 30, 2024 | 35.89 Mn |
| Jun 30, 2024 | 33.69 Mn |
| Mar 31, 2024 | 28.00 Mn |
| Dec 31, 2023 | 28.00 Mn |
| Sep 30, 2023 | 30.01 Mn |
| Jun 30, 2023 | 30.01 Mn |
| Mar 31, 2023 | 30.01 Mn |
| Dec 31, 2022 | 30.01 Mn |
| Sep 30, 2022 | 31.99 Mn |
| Jun 30, 2022 | 31.99 Mn |
| Mar 31, 2022 | 31.99 Mn |
| Dec 31, 2021 | 31.99 Mn |
| Sep 30, 2021 | 18,000.00 |
| Jun 30, 2021 | 18,000.00 |